Tower Research Capital (TRC)’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Tower Research Capital (TRC)’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-6,990	Closed	-$240K	–	5509
2014 Q4	$240K	Buy	6,990 +6,476	+1,260%	+$211K	0.02%	257
2014 Q3	$15K	Sell	514 -6,542	-93%	-$139K	﹤0.01%	2568
2014 Q2	$142K	Buy	+7,056	New	+$162K	0.02%	730
2014 Q1	–	Sell	-300	Closed	-$6K	–	5415
2013 Q4	$6K	Sell	300 -1,882	-86%	-$35.5K	﹤0.01%	3471
2013 Q3	$39K	Buy	2,182 +1,832	+523%	+$33.1K	﹤0.01%	2149
2013 Q2	$6K	Buy	+350	New	+$5.59K	﹤0.01%	2884

Other funds holding AUXL

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Tower Research Capital (TRC)'s AUXL Position: Q1 2015 in Review

Tower Research Capital (TRC) sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 6,990 shares — an estimated $240K sold.

Tower Research Capital (TRC) first reported a position in AUXL in Q2 2013 and held it in 6 quarters. The position peaked at $240K in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

Tower Research Capital (TRC) reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Tower Research Capital (TRC) sold 6,990 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $240K.
Tower Research Capital (TRC) first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 6 quarters.
Tower Research Capital (TRC)'s AUXILIUM PHARAMCEUTICALS INC position peaked at $240K in Q4 2014.
1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2015, filed 12 May 2015.